Delivery Order SPE2DB24D3013-SPE2DB25FFMRR
- Not listed
- The Defense Logistics Agency awarded a $7,804.29 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injection). This contract represents a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. As a leading pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,833.32 on September 3, 2025, for the supply of Forteo 560 mcg/2.24 mL pen injections. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction. The contract is set to complete by September 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger...
- The Defense Logistics Agency awarded a $2,601.43 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) with an ultimate completion date of August 22, 2025. This non-competitive delivery order represents a single pharmaceutical procurement from the company's extensive federal contract portfolio. The place of performance is identified as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a $30,571.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) on May 14, 2025, with completion targeted for May 15, 2025. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of $999,999,999.00 and extends through December 2026. The award was...
- The Defense Logistics Agency awarded a $7,201.22 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Forteo 560 mcg/2.24 mL pen injections. This firm fixed-price contract, with a completion date of September 2, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award involved no set-aside designation and was competitively awarded....
- The Defense Logistics Agency awarded a $1,833.32 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injections). This firm fixed-price delivery order, which is expected to be completed by August 25, 2025, represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The award is not set-aside and was competitively awarded, reflecting the contractor's...
- AmerisourceBergen Drug Corp was awarded a $54,516.23 delivery order contract by the Defense Logistics Agency on July 22, 2025, for the supply of Forteo (560 mcg/2.24 ml pen injections). The contract is set to be completed by July 23, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injections) with a ceiling value of $16,198.68. This firm fixed-price delivery order, which is due for completion by August 8, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award utilized no set-aside designation and was competitively awarded. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,601.43 to AmerisourceBergen Drug Corp for Forteo (560 mcg/2.24 mL pen injections) on August 13, 2025, with completion targeted for August 14, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injection). The contract, valued at $2,601.43, is a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFMRRDelivery Order
The Defense Logistics Agency awarded a $7,807.46 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Forteo (560 mcg/2.24 ml pen injections). This competitively awarded, firm fixed-price contract is a non-set-aside delivery order with an ultimate completion date of June 20, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, branded and generic drugs, and medical devices. The current delivery order for Forteo, an osteoporosis medication, exemplifies the company's role in fulfilling specialized pharmaceutical needs across the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.8k | 6/18/25 |